Phase II trial of GTX chemotherapy in metastatic pancreatic cancer

被引：0
|
作者：
Fine, R.
Moorer, G.
Sherman, W.
Chu, K.
Maurer, M.
Chabot, J.
Postolov, I.
Prowda, J.
Schreibman, S.
Levitz, J.
机构：
[1] Columbia Univ, Med Ctr, New York, NY USA
[2] Morristown Mem Hosp, Morristown, NJ USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4623
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Salvage chemotherapy of metastatic breast cancer with docetaxel and Gemcitabine: A multicenter phase II trial
    Mavroudis, D
    Malamos, N
    Giannakakis, T
    Alexopoulos, A
    Potamianou, A
    Rigatos, G
    Kosmas, C
    Sarra, E
    Papadouris, S
    Georgoulias, V
    ANNALS OF ONCOLOGY, 1998, 9 : 19 - 19
  • [22] PHASE-II TRIAL OF MENOGARIL AS INITIAL CHEMOTHERAPY FOR METASTATIC BREAST-CANCER
    KENNEDY, MJ
    DONEHOWER, RC
    GROCHOW, LB
    ETTINGER, DS
    FETTING, JH
    ABELOFF, MD
    INVESTIGATIONAL NEW DRUGS, 1990, 8 (03) : 289 - 294
  • [23] Improving outcome of chemotherapy of metastatic breast cancer by docosahexaenoic acid: a phase II trial
    Bougnoux, P.
    Hajjaji, N.
    Ferrasson, M. N.
    Giraudeau, B.
    Couet, C.
    Le Floch, O.
    BRITISH JOURNAL OF CANCER, 2009, 101 (12) : 1978 - 1985
  • [24] Sorafenib plus chemotherapy versus chemotherapy alone in advanced pancreatic cancer: A randomized phase II trial
    Cascinu, S.
    Berardi, R.
    Sobrero, A. F.
    Labianca, R.
    Bidoli, P.
    Siena, S.
    Ferraris, D.
    Barni, S.
    Cengarle, R.
    Monteforte, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [25] A multicenter analysis of GTX chemotherapy in patients with locally advanced and metastatic pancreatic adenocarcinoma
    Ana De Jesus-Acosta
    George R. Oliver
    Amanda Blackford
    Katharine Kinsman
    Edna I. Flores
    Lalan S. Wilfong
    Lei Zheng
    Ross C. Donehower
    David Cosgrove
    Daniel Laheru
    Dung T. Le
    Ki Chung
    Luis A. Diaz
    Cancer Chemotherapy and Pharmacology, 2012, 69 : 415 - 424
  • [26] Phase II study of modified FOLFIRINOX for chemotherapy-naive patients with metastatic pancreatic cancer
    Ueno, Makoto
    Ozaka, Masato
    Ishii, Hiroshi
    Sato, Tosiya
    Ikeda, Masafumi
    Uesugi, Kazuhiro
    Sata, Naohiro
    Miyashita, Kouichirou
    Mizuno, Nobumasa
    Tsuji, Kunihiro
    Okusaka, Takuji
    Furuse, Junji
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [27] Phase II study of FOLFIRINOX for chemotherapy-naive Japanese patients with metastatic pancreatic cancer
    Okusaka, Takuji
    Ikeda, Masafumi
    Fukutomi, Akira
    Ioka, Tatsuya
    Furuse, Junji
    Ohkawa, Shinichi
    Isayama, Hiroyuki
    Boku, Narikazu
    CANCER SCIENCE, 2014, 105 (10) : 1321 - 1326
  • [28] Phase II trial of imatinib mesylate in patients with metastatic. unresectable pancreatic cancer.
    Gharibo, MM
    Juvidian, P
    Patrick-Miller, L
    Zheng, L
    Craig, J
    Guensch, L
    Wojtaszek, C
    Poplin, E
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 353S - 353S
  • [29] Phase II trial of combined regional hyperthermia and gemcitabine for locally advanced or metastatic pancreatic cancer
    Ishikawa, Takeshi
    Kokura, Satoshi
    Sakamoto, Naoyuki
    Ando, Takashi
    Imamoto, Eiko
    Hattori, Takeshi
    Oyamada, Hirokazu
    Yoshinami, Naomi
    Sakamoto, Masafumi
    Kitagawa, Kazutomo
    Okumura, Yoko
    Yoshida, Naohisa
    Kamada, Kazuhiro
    Katada, Kazuhiro
    Uchiyama, Kazuhiko
    Handa, Osamu
    Takagi, Tomohisa
    Yasuda, Hiroaki
    Sakagami, Junichi
    Konishi, Hideyuki
    Yagi, Nobuaki
    Naito, Yuji
    Yoshikawa, Toshikazu
    INTERNATIONAL JOURNAL OF HYPERTHERMIA, 2012, 28 (07) : 597 - 604
  • [30] Phase II trial of oral S-1 combined with gemcitabine in metastatic pancreatic cancer
    K Nakamura
    T Yamaguchi
    T Ishihara
    K Sudo
    H Kato
    H Saisho
    British Journal of Cancer, 2006, 94 : 1575 - 1579
12345